Follow
Richard Jackson
Title
Cited by
Cited by
Year
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised …
JP Neoptolemos, DH Palmer, P Ghaneh, EE Psarelli, JW Valle, ...
The Lancet 389 (10073), 1011-1024, 2017
18432017
Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study
JW Valle, D Palmer, R Jackson, T Cox, JP Neoptolemos, P Ghaneh, ...
Journal of clinical oncology 32 (6), 504-512, 2014
4412014
Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial
W Greenhalf, P Ghaneh, JP Neoptolemos, DH Palmer, TF Cox, RF Lamb, ...
Journal of the National Cancer Institute 106 (1), djt347, 2014
2952014
Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of …
AR Pettitt, R Jackson, S Carruthers, J Dodd, S Dodd, M Oates, ...
Journal of Clinical Oncology 30 (14), 1647-1655, 2012
2372012
The impact of positive resection margins on survival and recurrence following resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma
P Ghaneh, J Kleeff, CM Halloran, M Raraty, R Jackson, J Melling, O Jones, ...
Annals of surgery 269 (3), 520-529, 2019
2232019
Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases
RP Jones, R Jackson, DFJ Dunne, HZ Malik, SW Fenwick, GJ Poston, ...
Journal of British Surgery 99 (4), 477-486, 2012
2222012
Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial
A Sharp, C Cornforth, R Jackson, J Harrold, MA Turner, LC Kenny, ...
The Lancet Child & Adolescent Health 2 (2), 93-102, 2018
2192018
Patterns of recurrence after resection of pancreatic ductal adenocarcinoma: a secondary analysis of the ESPAC-4 randomized adjuvant chemotherapy trial
RP Jones, EE Psarelli, R Jackson, P Ghaneh, CM Halloran, DH Palmer, ...
JAMA surgery 154 (11), 1038-1048, 2019
1792019
Effect of specialist decision-making on treatment strategies for colorectal liver metastases
RP Jones, JN Vauthey, R Adam, M Rees, D Berry, R Jackson, N Grimes, ...
Journal of British Surgery 99 (9), 1263-1269, 2012
1632012
Impact of viral status on survival in patients receiving sorafenib for advanced hepatocellular cancer: a meta-analysis of randomized phase III trials
R Jackson, EE Psarelli, S Berhane, H Khan, PJ Johnson
Journal of Clinical Oncology 35 (6), 622-628, 2017
1582017
Chemotherapy and radiotherapy for advanced pancreatic cancer
V Chin, A Nagrial, K Sjoquist, CA O'Connor, L Chantrill, AV Biankin, ...
Cochrane Database of Systematic Reviews, 2018
1442018
International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer
K Takaori, C Bassi, A Biankin, TB Brunner, I Cataldo, F Campbell, ...
Pancreatology 16 (1), 14-27, 2016
1002016
HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): a randomized controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible …
RJ Shaw, CJ Butterworth, P Silcocks, BT Tesfaye, M Bickerstaff, ...
International Journal of Radiation Oncology* Biology* Physics 104 (3), 530-539, 2019
942019
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic …
P Ghaneh, D Palmer, S Cicconi, R Jackson, CM Halloran, C Rawcliffe, ...
The Lancet Gastroenterology & Hepatology 8 (2), 157-168, 2023
932023
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre …
G Middleton, DH Palmer, W Greenhalf, P Ghaneh, R Jackson, T Cox, ...
The Lancet Oncology 18 (4), 486-499, 2017
722017
The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer
M Thornton, MA Aslam, EM Tweedle, C Ang, F Campbell, R Jackson, ...
International journal of cancer 133 (6), 1408-1418, 2013
662013
European Study Group for Pancreatic Cancer. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC …
JP Neoptolemos, DH Palmer, P Ghaneh, EE Psarelli, JW Valle, ...
Lancet 389 (10073), 1011-1024, 2017
652017
Head and neck cancer surgery during the COVID‐19 pandemic: an international, multicenter, observational cohort study
COVIDSurg Collaborative, R Shaw, SC Winter, J Glasbey, MWS Ho, ...
Cancer 127 (14), 2476-2488, 2021
592021
The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer
J Kleeff, E Costello, R Jackson, C Halloran, W Greenhalf, P Ghaneh, ...
British journal of cancer 115 (7), 887-894, 2016
572016
Diagnostic accuracy of individual antenatal tools for prediction of small‐for‐gestational age at birth
B Poljak, U Agarwal, R Jackson, Z Alfirevic, A Sharp
Ultrasound in Obstetrics & Gynecology 49 (4), 493-499, 2017
492017
The system can't perform the operation now. Try again later.
Articles 1–20